SCHEMBL15969815

SCHEMBL15969815

CNCCC1Cc2ccc(O)cc2C(C(N)=O)=C1C(N)=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 4/20 0.39
MTNR1B P49286 4/20 0.39
NQO2 P16083 1/20 0.39
MEN1 O00255 2/20 0.36
GLA P06280 2/20 0.36
KMT2A Q03164 2/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
LMNA P02545 2/20 0.36
NPSR1 Q6W5P4 2/20 0.36
GAA P10253 1/20 0.36
NPC1 O15118 1/20 0.36
NR1I2 O75469 1/20 0.36
GMNN O75496 1/20 0.36
USP2 O75604 1/20 0.36
TP53 P04637 1/20 0.36
CYP1A2 P05177 1/20 0.36
HSP90AA1 P07900 1/20 0.36
CYP3A4 P08684 1/20 0.36
CYP2D6 P10635 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15969330 0.90 MEN1 (0.45) MTNR1AMTNR1BNQO2MEN1GLA
SCHEMBL15969573 0.76 CYP19A1 (0.42) MEN1GLAKMT2AGAATSHR
SCHEMBL15970366 0.76 CYP19A1 (0.56) ESR1ESR2CYP19A1
SCHEMBL15969572 0.68 CYP19A1 (0.49) MEN1GLAKMT2AKDM4EALDH1A1
SCHEMBL15969586 0.67 CYP19A1 (0.67) MEN1GLAKMT2AKDM4EALDH1A1
SCHEMBL20809854 0.64 MEN1 (0.39) MTNR1AMTNR1BNQO2MEN1GLA
SCHEMBL8030964 0.62 MEN1 (0.44) MEN1GLAKMT2AKDM4EALDH1A1
SCHEMBL14380129 0.61 ESR1 (0.59) MTNR1AMTNR1BNQO2ESR1ESR2
SCHEMBL6935266 0.61 ACHE (0.66) PBRM1ACHEESR1ESR2CYP19A1
SCHEMBL29979385 0.61 ACHE (0.66) PBRM1ACHEESR1ESR2CYP19A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140243335-A1 SUBSTITUTED HYDOXAMIC ACIDS AND USES THEREOF MILLENNIUM PHARMACEUTICALS, INC. (US) 2014-08-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140243335-A1 SUBSTITUTED HYDOXAMIC ACIDS AND USES THEREOF HDAC6, HDAC1, H1-3 MTNR1A 1616/4885MTNR1B 1109/4885NQO2 42/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.